Which factor have more adverse effect on ocular surface of patients treated with antiglaucoma drops; drug type, number of drugs or drug intensity?

Our results showed that the main factor contrubuting to OSD and MGD were prostaglandin analog therapy as a drug type. Management of ocular surface disease in glaucomatous patients is important when trying to reduce further ocular morbidity.

Authors

Institutions

Publication Details

Journal
Cutaneous and Ocular Toxicology
Published
2025-03-19
DOI
https://doi.org/10.1080/15569527.2025.2479832
Citations
2
Primary Topic
Glaucoma and retinal disorders
Type
article
Field-Weighted Citation Impact
3.41
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Which factor have more adverse effect on ocular surface of patients treated with antiglaucoma drops; drug type, number of drugs or drug intensity?

Yesim Altay
2 citations
Cutaneous and Ocular Toxicology
Glaucoma and retinal disorders
3.41
article

Which factor have more adverse effect on ocular surface of patients treated with antiglaucoma drops; drug type, number of drugs or drug intensity?

Yesim Altay
article en
2 citations

Abstract

Our results showed that the main factor contrubuting to OSD and MGD were prostaglandin analog therapy as a drug type. Management of ocular surface disease in glaucomatous patients is important when trying to reduce further ocular morbidity.

Cutaneous and Ocular ToxicologyVol. 44(2)
Ufuk University (TR)
Openalex Percentile: Top 10%
Glaucoma and retinal disorders
3.41
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Which factor have more adverse effect on ocular surface of patients treated with antiglaucoma drops; drug type, number of drugs or drug intensity? — Yesim Altay · Cutaneous and Ocular Toxicology (2025) | TGRS Research Map | TGRS